Claudia Sorrentino
Parma, 43126, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Frequency of circulating CD8+CD73+T cells is associated with survival in nivolumab-treated melanoma patients.
Journal: Journal of translational medicine
Published: October 23, 2019
Blockade of Oncogenic NOTCH1 with the SERCA Inhibitor CAD204520 in T Cell Acute Lymphoblastic Leukemia.
Journal: Cell chemical biology
Published: July 04, 2019
Corrigendum: Adenosine A2A Receptor Stimulation Inhibits TCR-Induced Notch1 Activation in CD8+T-Cells.
Journal: Frontiers in immunology
Published: March 12, 2019
Therapeutic Targeting of Notch Signaling Pathway in Hematological Malignancies.
Journal: Mediterranean journal of hematology and infectious diseases
Published: March 03, 2019
Adenosine A2A Receptor Stimulation Inhibits TCR-Induced Notch1 Activation in CD8+T-Cells.
Journal: Frontiers in immunology
Published: October 12, 2018
Notch Signaling Regulates Mitochondrial Metabolism and NF-κB Activity in Triple-Negative Breast Cancer Cells via IKKα-Dependent Non-canonical Pathways.
Journal: Frontiers in oncology
Published: August 18, 2018
Soluble CD73 as biomarker in patients with metastatic melanoma patients treated with nivolumab.
Journal: Journal of translational medicine
Published: September 23, 2017
Activation of the A2B adenosine receptor in B16 melanomas induces CXCL12 expression in FAP-positive tumor stromal cells, enhancing tumor progression.
Journal: Oncotarget
Published: May 05, 2016
Myeloid-derived suppressor cells contribute to A2B adenosine receptor-induced VEGF production and angiogenesis in a mouse melanoma model.
Journal: Oncotarget
Published: April 20, 2015
Showing 1-10 of 10
Last Updated: 09/26/2026